Rare Mesothelioma Subtype Less Likely to Respond to Treatment
A new meta-analysis confirms that people with the sarcomatoid type of mesothelioma are less likely to respond to systemic chemotherapy than are people with other histological subtypes. Citing a lack of research on the responsiveness of different types of mesothelioma, scientists with the Mayo Clinic in Minnesota and the Levine Cancer Institute in Charlotte, NC reviewed the medical literature for any studies that broke down responses by histological subtype. Of the 544 studies analyzed, 30 included sarcomatoid mesothelioma patients and met the trial criteria that patients be treated only with chemotherapy. The selected studies included a total of 1,475 mesothelioma patients. Sixty-eight percent of patients (1,011) had the epithelioid variety of mesothelioma, the most common type. Just over 13 percent … Continue reading Rare Mesothelioma Subtype Less Likely to Respond to Treatment
“My Name is Paul Kraus and I Have Survived Mesothelioma for Over 20 Years.”
In 1997 I was diagnosed with mesothelioma. The doctors gave me just a few short months to live...
But here I am, 20 years later, alive and well.
I wrote a book explaining how I became the longest living mesothelioma survivor in the world.
Today, I'd like to give you a copy for free because I want more people to survive this disease.
All you have to do is click the button below now. You will receive the book within 72 hours.
I wish you good health.
Sincerely,
"It has been over four years now and I can honestly say I am doing great. I highly recommend this book because it is inspirational and educational."
Get your free copy of
“Surviving Mesothelioma” Today!